Combinations of a liposomal water-soluble camptothecin with cetuximab or bevacizumab

作者: Paul Tardi , Lawrence Mayer , David Bermudes

DOI:

关键词: LiposomeCetuximabEpidermal growth factor receptorTherapeutic effectBevacizumabCamptothecinPharmacologyGrowth factorChemistryCancer

摘要: Compositions which comprise a liposomal water-soluble camptothecin and optionally fluoropyrimidine in combination with vascular epithelial growth factor (VEGF) inhibitor such as cetuximab or an epidermal receptor (EGFR) bevacizumab are useful achieving enhanced therapeutic effects for the treatment of cancer.

参考文章(34)
Marcel Bally, Lawrence Mayer, Sharon Johnstone, Murray Webb, Paul Tardi, Combination compositions of camptothecins and fluoropyrimidines ,(2004)
Rodney Caughren Schnur, Lee Daniel Arnold, Alkynl and azido-substituted 4-anilinoquinazolines ,(2008)
Patricia Vrignaud, Marie-Christine Bissery, Marielle Chiron-Blondel, Pascale Lejeune, Antitumour combinations containing a vegf inhibiting agent and irinotecan ,(2008)
Kenneth Kolinsky, Jianping Chen, Brian Higgins, Treatment with irinotecan (CPT-11) and an EGFR-inhibitor ,(2005)
Andrew S. Janoff, Liposomes: Rational Design ,(1998)
Blair Narog, Laura Kay Shawver, Klaus Peter Hirth, Gerald Mcmahon, Peng Cho Tang, Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders ,(1997)
Choon K. Oh, Francis Ignatious, Stabilized topotecan liposomal composition and methods ,(2004)
Jürgen Mestan, Paul William Manley, Guido Bold, Pascal Furet, Jose Brüggen, Jeanette Marjorie Wood, Stefano Ferrari, Karl-Heinz Thierauch, Andreas Menrad, Martin Krüger, Dieter Seidelmann, Eckhard Ottow, Andreas Huth, Michael Schirner, Antrhranilic acid amides and the use thereof as medicaments ,(1999)